Insiders · Profile

EWALD STEPHEN P

General Counsel & Corp. Secy. at Medpace. Filing since 29 Mar 2019. CIK 0001677297

Company
Date
Role
Action
Shares
Amount
Of holding
28 May 2026
General Counsel & Corp. Secy.
Sold at will
16,349
$7.36M
44.6%
27 Oct 2025
General Counsel & Corp. Secy.
Sold at will
15,230
$9.12M
53.3%
28 Jul 2025
General Counsel & Corp. Secy.
Sold at will
3,000
$1.35M
22.5%
27 Feb 2025
General Counsel & Corp. Secy.
Bought
2
$652.22
0.0%
1 Mar 2024
General Counsel & Corp. Secy.
Sold at will
350
$140.28K
2.6%
29 Feb 2024
General Counsel & Corp. Secy.
Sold at will
1,163
$457.65K
7.8%
27 Jul 2023
General Counsel & Corp. Secy.
Sold at will
21,850
$5.56M
59.5%
27 Oct 2022
General Counsel & Corp. Secy.
Sold, plan not stated
6,500
$1.43M
30.4%
26 Oct 2021
General Counsel & Corp. Secy.
Sold, plan not stated
10,000
$2.09M
41.9%
15 Apr 2021
General Counsel & Corp. Secy.
Sold, plan not stated
3,800
$703.68K
21.5%
14 Apr 2021
General Counsel & Corp. Secy.
Sold, plan not stated
1,200
$216.80K
8.0%
9 Feb 2021
General Counsel & Corp. Secy.
Sold, plan not stated
10,000
$1.55M
41.9%
10 Dec 2020
General Counsel & Corp. Secy.
Sold, plan not stated
10,000
$1.40M
41.9%
10 Aug 2020
General Counsel & Corp. Secy.
Sold, plan not stated
7,400
$899.62K
68.9%
18 Oct 2019
General Counsel & Corp. Secy.
Sold, plan not stated
8,000
$618.40K
100%
29 Mar 2019
General Counsel & Corp. Secy.
Sold, plan not stated
7,946
$460.47K
100%
16 decisions on file.